What is Kyverna Therapeutics, Inc.'s net investment in lease?

Kyverna Therapeutics, Inc. (KYTX) reported net investment in lease of $8.19M in Q1 2026.

How has Kyverna Therapeutics, Inc.'s net investment in lease changed year-over-year?

Kyverna Therapeutics, Inc.'s net investment in lease increased by 42.1% year-over-year, from $5.76M to $8.19M.

What is the long-term trend for Kyverna Therapeutics, Inc.'s net investment in lease?

Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s net investment in lease has grown at a -25.9% compound annual growth rate (CAGR), from $6.49M to $3.57M.

Kyverna Therapeutics, Inc. KYTX Net Investment in Lease

Net Investment in Lease at other companies

Climb Bio, Inc.CLYM

——

Artiva Biotherapeutics, Inc.ARTV

——

Iovance Biotherapeutics, Inc.IOVA

——

Viridian Therapeutics, Inc.VRDN

——

Vor BiopharmaVOR

——

Allogene TherapeuticsALLO

——

Other financials

Income statement

See full

Operating income-$41.4M+12.7%

Net income-$39.7M+11.0%

EPS (diluted)-$0.66+35.9%

Balance sheet

See full

Cash & equivalents$32.2M-43.4%

Total debt$9.2M+32.1%

Total equity$195.6M-12.7%

Total assets$257.0M-1.4%

Cash flow

See full

Operating cash flow-$41.6M+7.4%

CapEx$2.0K-98.0%

Free cash flow-$33.5M+10.8%

Valuation

See full

Market cap$498.52M+276%

Enterprise value$475.49M+475%

Returns & leverage

See full

Return on equity-74.5%+74.4pp

Debt / equity0×0.0×

Current ratio8.1×+0.7×

Where this comes from

Reported directly by Kyverna Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kyverna Therapeutics, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kyverna Therapeutics, Inc.'s net investment in lease?: Kyverna Therapeutics, Inc. (KYTX) reported net investment in lease of $8.19M in Q1 2026.
How has Kyverna Therapeutics, Inc.'s net investment in lease changed year-over-year?: Kyverna Therapeutics, Inc.'s net investment in lease increased by 42.1% year-over-year, from $5.76M to $8.19M.
What is the long-term trend for Kyverna Therapeutics, Inc.'s net investment in lease?: Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s net investment in lease has grown at a -25.9% compound annual growth rate (CAGR), from $6.49M to $3.57M.